Article
Perlmutter steps down as Merck R&D lead as early research chief Li steps in
Rating:
0.0
Views:
43
Likes:
1
Library:
1
After seven years running Merck's R&D engine, much of which has revolved around cancer blockbuster Keytruda and, now, COVID-19 vaccines, Roger Perlmutter, M.D., Ph.D., is hitting the exit.
Rate This Post
-
Education
-
Communication
-
Entertainment
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value